TY  - JOUR
A1  - Albrecht, Franziska
A1  - Mueller, Karsten
A1  - Ballarini, Tommaso
A1  - Lampe, Leonie
A1  - Diehl-Schmid, Janine
A1  - Fassbender, Klaus
A1  - Fliessbach, Klaus
A1  - Jahn, Holger
A1  - Jech, Robert
A1  - Kassubek, Jan
A1  - Kornhuber, Johannes
A1  - Landwehrmeyer, Bernhard
A1  - Lauer, Martin
A1  - Ludolph, Albert C.
A1  - Lyros, Epameinondas
A1  - Prudlo, Johannes
A1  - Schneider, Anja
A1  - Synofzik, Matthis
A1  - Wiltfang, Jens
A1  - Danek, Adrian
A1  - Otto, Markus
A1  - Schroeter, Matthias L.
T1  - Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging
JF  - Cortex
N2  - Alien limb phenomenon is a rare syndrome associated with a feeling of non-belonging and disowning toward one's limb. In contrast, anarchic limb phenomenon leads to involuntary but goal-directed movements. Alien/anarchic limb phenomena are frequent in corticobasal syndrome (CBS), an atypical parkinsonian syndrome characterized by rigidity, akinesia, dystonia, cortical sensory deficit, and apraxia. The structure function relationship of alien/anarchic limb was investigated in multi centric structural magnetic resonance imaging (MRI) data. Whole-group and single subject comparisons were made in 25 CBS and eight CBS-alien/anarchic limb patients versus controls. Support vector machine was used to see if CBS with and without alien/anarchic limb could be distinguished by structural MRI patterns. Whole-group comparison of CBS versus controls revealed asymmetric frontotemporal atrophy. CBS with alien/anarchic limb syndrome versus controls showed frontoparietal atrophy including the supplementary motor area contralateral to the side of the affected limb. Exploratory analysis identified frontotemporal regions encompassing the pre-/and postcentral gyrus as compromised in CBS with alien limb syndrome. Classification of CBS patients yielded accuracies of 79%. CBS-alien/anarchic limb syndrome was differentiated from CBS patients with an accuracy of 81%. Predictive differences were found in the cingulate gyrus spreading to frontomedian cortex, postcentral gyrus, and temporoparietoocipital regions. We present the first MRI-based group analysis on CBS-alien/anarchic limb. Results pave the way for individual clinical syndrome prediction and allow understanding the underlying neurocognitive architecture. (C) 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
KW  - Alien limb syndrome
KW  - Anarchic limb syndrome
KW  - Corticobasal syndrome
KW  - Diagnosis prediction
KW  - Support vector machine
Y1  - 2019
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-221040
VL  - 117
ER  - 
TY  - JOUR
A1  - Müller, Thomas
A1  - Mueller, Bernhard Klaus
A1  - Riederer, Peter
T1  - Perspective: Treatment for disease modification in chronic neurodegeneration
JF  - Cells
N2  - Symptomatic treatments are available for Parkinson's disease and Alzheimer's disease. An unmet need is cure or disease modification. This review discusses possible reasons for negative clinical study outcomes on disease modification following promising positive findings from experimental research. It scrutinizes current research paradigms for disease modification with antibodies against pathological protein enrichment, such as α-synuclein, amyloid or tau, based on post mortem findings. Instead a more uniform regenerative and reparative therapeutic approach for chronic neurodegenerative disease entities is proposed with stimulation of an endogenously existing repair system, which acts independent of specific disease mechanisms. The repulsive guidance molecule A pathway is involved in the regulation of peripheral and central neuronal restoration. Therapeutic antagonism of repulsive guidance molecule A reverses neurodegeneration according to experimental outcomes in numerous disease models in rodents and monkeys. Antibodies against repulsive guidance molecule A exist. First clinical studies in neurological conditions with an acute onset are under way. Future clinical trials with these antibodies should initially focus on well characterized uniform cohorts of patients. The efficiency of repulsive guidance molecule A antagonism and associated stimulation of neurogenesis should be demonstrated with objective assessment tools to counteract dilution of therapeutic effects by subjectivity and heterogeneity of chronic disease entities. Such a research concept will hopefully enhance clinical test strategies and improve the future therapeutic armamentarium for chronic neurodegeneration.
KW  - neurodegeneration
KW  - repulsive guidance molecule A
KW  - neuroprotection
KW  - repair
KW  - oxidative stress
KW  - apoptosis
KW  - neurogenesis
Y1  - 2021
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236644
SN  - 2073-4409
VL  - 10
IS  - 4
ER  -